1014 related articles for article (PubMed ID: 27390021)
1. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Arlt W; Bancos I; Dralle H; Newell-Price J; Sahdev A; Tabarin A; Terzolo M; Tsagarakis S; Dekkers OM
Eur J Endocrinol; 2016 Aug; 175(2):G1-G34. PubMed ID: 27390021
[TBL] [Abstract][Full Text] [Related]
2. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Tsagarakis S; Terzolo M; Tabarin A; Sahdev A; Newell-Price J; Pelsma I; Marina L; Lorenz K; Bancos I; Arlt W; Dekkers OM
Eur J Endocrinol; 2023 Jul; 189(1):G1-G42. PubMed ID: 37318239
[TBL] [Abstract][Full Text] [Related]
3. [Adrenal incidentaloma - differential diagnosis and management].
Remde H; Kimpel O; Fassnacht M
Dtsch Med Wochenschr; 2022 Jan; 147(3):85-91. PubMed ID: 35100640
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
[TBL] [Abstract][Full Text] [Related]
5. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for the management of adrenal incidentalomas: what is pertinent for radiologists?
Sahdev A
Br J Radiol; 2017 Apr; 90(1072):20160627. PubMed ID: 28181818
[TBL] [Abstract][Full Text] [Related]
7. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma").
NIH Consens State Sci Statements; 2002 Feb 4-6; 19(2):1-25. PubMed ID: 14768652
[TBL] [Abstract][Full Text] [Related]
8. Management of adrenal incidentalomas: Working through uncertainty.
Cambos S; Tabarin A
Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101427. PubMed ID: 32448594
[TBL] [Abstract][Full Text] [Related]
9. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.
Mantero F; Masini AM; Opocher G; Giovagnetti M; Arnaldi G
Horm Res; 1997; 47(4-6):284-9. PubMed ID: 9167966
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of new recommendations for adrenal incidentalomas in the evaluation of excessive cortisol secretion and follow-up.
Ruiz A; Michalopoulou T; Megia A; Näf S; Simón-Muela I; Solano E; Martínez L; Vendrell J
Eur J Clin Invest; 2019 Feb; 49(2):e13048. PubMed ID: 30412278
[TBL] [Abstract][Full Text] [Related]
11. Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition.
Araujo-Castro M; Iturregui Guevara M; Calatayud Gutiérrez M; Parra Ramírez P; Gracia Gimeno P; Hanzu FA; Lamas Oliveira C
Endocrinol Diabetes Nutr (Engl Ed); 2020; 67(6):408-419. PubMed ID: 32349941
[TBL] [Abstract][Full Text] [Related]
12. [Autonomous cortisol secretion : Laboratory artifact or disease?].
Riester A; Beuschlein F
Internist (Berl); 2022 Jan; 63(1):18-24. PubMed ID: 34709420
[TBL] [Abstract][Full Text] [Related]
13. Recent Updates on the Management of Adrenal Incidentalomas.
Park SS; Kim JH
Endocrinol Metab (Seoul); 2023 Aug; 38(4):373-380. PubMed ID: 37583083
[TBL] [Abstract][Full Text] [Related]
14. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
[TBL] [Abstract][Full Text] [Related]
15. Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
[TBL] [Abstract][Full Text] [Related]
16. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
[TBL] [Abstract][Full Text] [Related]
18. Subclinical Cushing's syndrome.
Reincke M
Endocrinol Metab Clin North Am; 2000 Mar; 29(1):43-56. PubMed ID: 10732263
[TBL] [Abstract][Full Text] [Related]
19. Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome.
Abe I; Sugimoto K; Miyajima T; Ide T; Minezaki M; Takeshita K; Takahara S; Nakagawa M; Fujimura Y; Kudo T; Miyajima S; Taira H; Ohe K; Ishii T; Yanase T; Kobayashi K
Intern Med; 2018 Sep; 57(17):2467-2472. PubMed ID: 29709936
[TBL] [Abstract][Full Text] [Related]
20. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
